BIGG

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer

Miller, R. E; Leary, A; Scott, C. L; Serra, V; Lord , C. J; Bowtell, D; Chang, D. K; Garsed, D. W; Jonkers, J; Ledermann, J. A; Nik-Zainal, S; Ray-Coquard, I; Shah, S. P; Matias-Guiu, X; Swisher, E. M; Yates, L. R.

The European Society for Medical Oncology (ESMO) Translational Research and Precision Medicine Working Group identified that there is currently uncertainty within the oncology community surrounding the different methods for HRD testing in HGSC. To address this, a collaborative project was launched with a...

Recombinación Homóloga/genética, Inhibidores de Poli(ADP-Ribosa) Polimerasas/uso terapéutico, Biomarcadores, Neoplasias de los Genitales Femeninos/diagnóstico, Mutación de Línea Germinal/genética

Texto completo

WHO guidelines for the prevention of sexual transmission of Zika virus

WHO published interim guidelines on the prevention of sexual transmission of Zika virus in September 2016, based on a limited amount of evidence under an emergency process during a public health emergency of international concern (PHEIC). The body of evidence has grown considerably since then, and WHO ex...